BUSINESS
Sun Pharma comes up with psoriasis treatment drug ‘ILUMYA’ in US
Sun Pharmaceutical Industries has launched its plaque psoriasis treatment drug ‘ILUMYA’ (tildrakizumab-asmn) 100 mg/mL in the United States. ILUMYA is an injectable…
pharma
CAREER
Alembic Pharma receives USFDA’s tentative approval for Alogliptin Tablet
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Alogliptin…
BUSINESS
Aurobindo Pharma receives USFDA’s nod for Azithromycin Oral Suspension
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Azithromycin Oral Suspension 100…
BUSINESS
Sun pharma expects to stabilize India business in FY19
Favorable demographics conditions will help the company to ensure reasonable volume growth in India Sun Pharmaceutical Industries is excepting its India business…
BUSINESS
Sun Pharma’s arm hikes stake in Ranbaxy Malaysia
Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has increased its shareholding in Ranbaxy Malaysia, Malaysia, by way of further purchase…